5th World Congress on Hepatitis & Liver Diseases
August 10-12, 2017 London, UK

Upcoming Conference

Hepatitis 2017
Hepatitis 2017 Report

5th World Congress on Hepatitis and Liver Diseases (Hepatitis-2017) organised by Conference Series LLC was held on August 10-12, 2017 at Park Inn by Radisson London Heathrow, London, UK. The conference highlighted the theme, “Early diagnosis, treatment of viral hepatitis and optimizing therapy costs”. It is an annual meeting for the study of recent advancements and management of Hepatitis and Liver diseases.

The conference was initiated with a warm welcome note from Honorable guests and our special thanks to Dr. Ming Luo, Georgia State University, USA and Dr. Ruchika Sharma, Decision Resources Group, India, the Honorable Moderators of the conference who contributed a major part for the success of this event. The conference was marked with the presence of renowned scientists, young researchers, students and business delegates driving the three days event into the path of success with thought provoking keynote and plenary presentations. Active participation and generous response were received from the Organizing Committee Members. Professors, Researchers, and Students from diverse groups made this conference as one of the most successful and productive event in 2017 from Conference Series LLC.

The highlights of the meeting were the enlightening keynote lectures from:

  • Maxwell Chait, Columbia University, USA on the topic, “Lower GI bleeding in patients with cirrhosis”.
  • Vincenzo Neri, University of Foggia, Italy, on the topic, “Acute Pancreatitis Treatment”.
  • Ann D Kwong, Trek Therapeutics, USA on the topic, “Why Highly Effective Drugs Are Not Enough: An Affordable Solution to Eradicating HCV”.
  • Ming Luo, Georgia State University, USA on the topic, “A Virus-like Particle of HBV preS Elicits Robust Immune Responses”.


The conference proceedings were carried out through various scientific sessions and plenary lectures:

  • Title: The Epidemiology of HCV and PWIDs in the United States by Seth Kuranz, Decision Resources Group, USA.
  • Title: Towards the first antibody-free serum biomarker assay for NAFLD presented by Bevin Gangadharan, University of Oxford, UK.
  • Title: Immune persistence after hepatitis B vaccination in infancy: Fact or fancy? presented by Terence T Lao, Chinese University of Hong Kong, Hong Kong.
  • Title: Hepatitis C and Sustainable Development Goals 2030 lectured by Ruchika Sharma, Decision Resources Group, India.
  • Title: Advances in Hepatology delivered by Maxwell Chait, Columbia University, USA.
  • Title: Impaired homocysteine metabolism in patients with alcoholic liver disease in Taiwan given by Suh Ching Yang, Taipei Medical University, Taiwan.
  • Title: Cost-effectiveness of maternal antiviral treatment for further preventing mother-to-infant hepatitis B virus transmission in China presented by Juan Yin, Xi’an Jiaotong University, China.
  • Title: Clinical trials and pharmacology of HeberNasvac, a newly registered therapeutic vaccine for chronic Hepatitis B: Crossroad of biotechnology, adjuvant strategies and Liver Immunology shared by Julio Cesar Aguilar Rubido, Center for Genetic Engineering and Biotechnology, Cuba.
  • Title: Anti HAV and anti HBs status in children with chronic liver disease at a super

speciality centre: need for urgent vaccination lectured by Arun Kumar Sharma, Post Graduate Institute of Medical Education and Research, India.

  • Title: Epidemiology and Disease Burden of Chronic Hepatitis C in Selected Middle Eastern Countries shared by Abdulrahman A Aljumah, King Saud bin Abdulaziz University for Health Sciences, Saudi Arabia.

Conference Series LLC has taken the privilege of felicitating Hepatitis 2017 Organizing Committee and Keynote Speakers who supported and contributed for the success of this event. Conference Series LLC, congratulate the Best Poster awardee Ruchika Sharma, Decision Resources Group, India.

We are glad to inform that all accepted abstracts for the conference have been indexed in Conference Series LLC Journal, Journal of Liver as a special issue.

We sincerely thank the Organizing Committee Members, Participants and Media Partners for their gracious presence and generous support, without which the conference would not have reached the pinnacle of success. With the unique feedback from the conference, Conference Series LLC would like to announce the commencement of the “6th  World Congress on Hepatitis and Liver Diseases” during June 18-20, 2018 in Dublin, Ireland.

Let us meet again @ Hepatitis 2018

Expert Presentations
Bevin Gangadharan

University of Oxford

Seth Kuranz

Decision Resources Group

Maxwell Chait

Columbia University

Vincenzo Neri

University of Foggia

Abdulrahman A Aljumah

King Saud bin Abdulaziz University for Health Sciences

Saudi Arabia
Terence T Lao

Chinese University of Hong Kong

Hong Kong
Ruchika Sharma

Decision Resources Group

Ann D Kwong

Trek Therapeutics

Ming Luo

Georgia State University

Animesh Dhar

Kansas University Medical Center

Qingyong Ma

Xian Jiaotong University

Juan Yin

Xi’an Jiaotong University

Suh Ching Yang

Taipei Medical University

Michael Jones

Imperial College

Suzhen Wang

Weifang Medical University

Julio Cesar Aguilar Rubido

Center for Genetic Engineering and Biotechnology

Arun Kumar Sharma

Post Graduate Institute of Medical Education and Research

Paul Desmond

Hepatitis B Positive Trust

Conference: Hepatitis 2017, Conference Series Conferences
35 Ruddlesway, Windsor,Berkshire, SL4 5SF
Contact: hepatitis@gastroconferences.org
Toll free: 0044-2033180199(USA & Canada),
0044-2033180199(Australia), 0044-2033180199(Europe)
Operated by: Editors - Journal of Liver, Journal of Liver Disease and Transplantation and Journal of Gastrointestinal & Digestive System
The Organizers reserve the rights to make changes and adjustment to the information in this website
Copyright 2023 Conference Series - All rights reserved